Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€373.10

€373.10

-0.610%
-2.3
-0.610%
€400.00

€400.00

 
14.06.21 / Tradegate WKN: 927079 / Symbol: ILMN / Name: Illumina / Stock / Healthcare Equipment & Supplies / Large Cap /
Latest predictions
-
21.12.20
26.35%
buy
-
22.09.20
65.23%
buy
€300.00
26.02.20
47.79%
buy
€315.70
13.07.19
35.60%
buy
€315.70
01.02.19
47.67%
buy
€343.44
07.01.19
36.98%
buy
Best running prediction
€400.00
27.11.17
86.08%
buy
Your prediction

Illumina Inc. Stock

The price for the Illumina Inc. stock decreased slightly today. Compared to yesterday there is a change of -€2.300 (-0.610%).
With 8 Buy predictions and not the single Sell prediction the community is currently very high on Illumina Inc..
With a target price of €400.00 there is a slightly positive potential of 7.210% for Illumina Inc. compared to the current price of €373.10.

Pros and Cons of Illumina Inc. in the next few years

Pros
?
Conscious of the environment
?
Brand
?
Market Position
Cons
?
Shareholder structure
?
Worthwhile Investment for the next years
?
Growth compared to competition
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Illumina Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Illumina Inc. -0.610% 5.754% 18.822% 22.973% 24.450% 50.056% 204.422%
Edwards Lifesciences Corp. 0.820% 5.443% 13.026% 37.982% 13.441% 478.071% -
Agilent Technologies Inc. 0.170% 5.492% 10.227% 55.686% 24.856% 108.874% 198.063%
Boston Scientific -0.870% 1.563% 2.572% 11.752% 19.843% 26.087% 71.096%

Comments

Buy Illumina Inc.
Show more

Buy Illumina Inc.
Show more

Buy Illumina Inc.
Show more

Other discussions about Illumina Inc. Stock

Trading Illumina Inc.

Trading Illumina Inc.

New thread Forum

News

Illumina Supports Nationwide Program across Belgium to Assess Whole Genome Sequencing for Developmental Disorders Diagnosishttp://wire.kapitall.com/wp-content/image-import/ILLUMINA1-430x323.jpg: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12128/Illumina_%28company%29_logo.jpg
Illumina Supports Nationwide Program across Belgium to Assess Whole Genome Sequencing for Developmental Disorders Diagnosis


Today, Illumina, Inc. (NASDAQ:ILMN) announced an agreement with the Belgian Genetic Centers to evaluate whole-genome sequencing (WGS) for the diagnosis of patients with intellectual disabilities

Illumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution in Thailand: https://mms.businesswire.com/media/20210531005030/en/881624/5/veriseq-nipt-solution-v2.jpg
Illumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution in Thailand


Illumina, Inc., the global leader in DNA sequencing and array-based technologies and Next Generation Genomic Co., Ltd. (NGG Thailand), the Association of Southeast Asian Nations (ASEAN) leaders in

Illumina To Webcast Upcoming Investor Conference http://wire.kapitall.com/wp-content/image-import/ILLUMINA1-430x323.jpg: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12128/Illumina_%28company%29_logo.jpg
Illumina To Webcast Upcoming Investor Conference


Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference:




  • Goldman Sachs 42nd Annual Global Healthcare Conference on June 10, 2021